0001936258 1 2026-06-05 2026-06-05 0001936258 2026-06-05 2026-06-05 pure shares iso4217:USD 0001936258 N/A EX-FILING FEES Ordinary Shares, nominal value euro 0.12 per share, to be issued under the ESPP S-8 S-8 NewAmsterdam Pharma Company N.V. false Equity true 1150000 26.76 30774000 0.0001381 4249.89 30774000 4249.89 0 4249.89 <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:3%;box-sizing:content-box;"></td> <td style="width:97%;box-sizing:content-box;"></td> </tr> <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;text-align:left;"> <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;">(1)</td> <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;">Pursuant to Rule 416(a) under the Securities Act of 1933, as amended (the “Securities Act”), this registration statement shall be deemed to cover any additional ordinary shares in the share capital of NewAmsterdam Pharma Company N.V. (the “Company”), nominal value of €0.12 per share (the “Ordinary Shares”), that may become issuable under the NewAmsterdam Pharma Company N.V. 2026 Employee Stock Purchase Plan (the “ESPP”) from time to time by reason of any stock dividend, stock split, recapitalization or other similar transaction effected without receipt of consideration that increases the number of outstanding shares of the Company’s Ordinary Shares. </td> </tr> <tr style="word-break:break-word;white-space:pre-wrap;text-align:left;"> <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"> </td> <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"> </td> </tr> <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;text-align:left;"> <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;">(2)</td> <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;">Represents Ordinary Shares reserved for issuance under ESPP and registered hereby.</td> </tr> <tr style="word-break:break-word;white-space:pre-wrap;text-align:left;"> <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"> </td> <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"> </td> </tr> <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;text-align:left;"> <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;">(3)</td> <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;">Estimated in accordance with Rule 457(c) and (h) under the Securities Act. The proposed maximum offering price per share and maximum aggregate offering price are calculated based on $31.48, the average of the high and low sale prices of the Company’s Ordinary Shares as reported on the Nasdaq Global Select Market on June 2, 2026. Pursuant to the ESPP, the purchase price of the Ordinary Shares reserved for issuance thereunder will be 85% of the lower of the fair market value of the Ordinary Shares on (i) the first day of the applicable offering period and (ii) the exercise date.</td> </tr> </table>